Home > Income Statement > ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS
Revenue

    Back to Income Statement
ALEMBIC PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

ALEMBIC PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹6,229 Cr₹5,653 Cr₹5,306 Cr₹5,393 Cr₹4,606 Cr

What is the latest Revenue of ALEMBIC PHARMACEUTICALS ?

The latest Revenue ratio of ALEMBIC PHARMACEUTICALS is ₹6,229 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹6,229 Cr
Mar2024₹5,653 Cr
Mar2023₹5,306 Cr
Mar2022₹5,393 Cr
Mar2021₹4,606 Cr

How is Revenue of ALEMBIC PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹6,229 Cr
10.19
Mar2024 ₹5,653 Cr
6.54
Mar2023 ₹5,306 Cr
-1.62
Mar2022 ₹5,393 Cr
17.10
Mar2021 ₹4,606 Cr -

Compare Revenue of peers of ALEMBIC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS ₹13,012.0 Cr 2.4% -10.4% -30.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,647.0 Cr 0.1% -0.4% 0.6% Stock Analytics
DIVIS LABORATORIES ₹157,862.0 Cr -1.1% -7.1% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,846.0 Cr 0.2% -4.5% 30.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,720.0 Cr 0.2% -4% 6% Stock Analytics
CIPLA ₹98,795.9 Cr 0% -9.1% -18.5% Stock Analytics


ALEMBIC PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS

2.4%

-10.4%

-30.1%

SENSEX

-3.5%

-12.5%

-6.5%


You may also like the below Video Courses